Position in ALKS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,187,397
-$9,622,224 QoQ
Shares Held
174,983
-69.0% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Derivatives in ALKS
reported options exposure · as of Jun 30, 2025CallValue
$2,145,750
CallShares
75,000
PutValue
$2,861
PutShares
100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $516,666,064 across 52 Drug Manufacturers - Specialty & Generic names. ALKS ranks #13 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,809,925 | $213,951,231 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,745,751 | $53,210,488 | |
| 3 | VTRS |
Viatris Inc
|
3,144,439 | $42,481,369 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,400,671 | $42,188,210 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
63,005 | $37,360,703 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
243,984 | $32,142,450 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
971,854 | $13,508,770 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
639,372 | $13,273,362 |
All Filings in ALKS
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,187,397 | 174,983 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $15,809,621 | 565,033 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $16,699,530 | 556,651 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $2,145,750 | 75,000 | Call | Sole | 2026-02-27 | |
| 2025-06-30 | $19,858,829 | 694,122 | Shares | Sole | 2026-02-27 | |
| 2025-06-30 | $2,861 | 100 | Put | Sole | 2026-02-27 | |
| 2025-03-31 | $13,866,781 | 419,951 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $12,245,345 | 425,777 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $11,865,827 | 423,931 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $4,893,214 | 203,038 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $6,354,952 | 234,760 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $11,880,180 | 428,269 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $6,397,147 | 228,388 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $6,412,649 | 204,877 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $7,904,277 | 280,393 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $8,303,747 | 317,786 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $6,378,608 | 285,652 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $1,457,952 | 48,941 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,429,027 | 54,315 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,797,322 | 249,240 | Shares | Sole | 2022-02-23 | |
| 2021-09-30 | $2,267,881 | 73,537 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $599,268 | 24,440 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,063,111 | 110,445 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $468,884 | 23,503 | Shares | Sole | 2021-02-11 | |
| 2020-06-30 | $106,755 | 5,500 | Call | Sole | 2020-08-12 | |
| 2020-06-30 | $1,449,072 | 74,656 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $174,482 | 12,100 | Put | Sole | 2020-05-13 | |
| 2020-03-31 | $122,570 | 8,500 | Call | Sole | 2020-05-13 | |
| 2020-03-31 | $1,680,492 | 116,539 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||